Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:CXF NASDAQ:ME NASDAQ:NEPT NASDAQ:RGC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCXFCI Canadian Convertible Bond ETF CommonC$10.63+1.5%C$10.40C$9.72▼C$10.80C$53.65M0.06464,449 shs3,005 shsME23andMe$0.50-35.3%$0.50$0.53▼$9.57$13.36M1.191.57 million shs29.28 million shsNEPTNeptune Wellness Solutions$0.39$0.19▼$28.00$906K2.19462,687 shs2.25 million shsRGCRegencell Bioscience$14.70+9.3%$14.04$0.09▼$83.60$6.65B2.16260,002 shs433,710 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCXFCI Canadian Convertible Bond ETF Common0.00%-1.21%+2.80%+4.11%+5.46%ME23andMe0.00%0.00%0.00%0.00%-91.82%NEPTNeptune Wellness Solutions0.00%0.00%0.00%0.00%0.00%RGCRegencell Bioscience0.00%+10.86%+15.75%+1,469,999,900.00%+1,469,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCXFCI Canadian Convertible Bond ETF CommonC$10.63+1.5%C$10.40C$9.72▼C$10.80C$53.65M0.06464,449 shs3,005 shsME23andMe$0.50-35.3%$0.50$0.53▼$9.57$13.36M1.191.57 million shs29.28 million shsNEPTNeptune Wellness Solutions$0.39$0.19▼$28.00$906K2.19462,687 shs2.25 million shsRGCRegencell Bioscience$14.70+9.3%$14.04$0.09▼$83.60$6.65B2.16260,002 shs433,710 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCXFCI Canadian Convertible Bond ETF Common0.00%-1.21%+2.80%+4.11%+5.46%ME23andMe0.00%0.00%0.00%0.00%-91.82%NEPTNeptune Wellness Solutions0.00%0.00%0.00%0.00%0.00%RGCRegencell Bioscience0.00%+10.86%+15.75%+1,469,999,900.00%+1,469,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCXFCI Canadian Convertible Bond ETF Common 0.00N/AN/AN/AME23andMe 0.00N/AN/AN/ANEPTNeptune Wellness Solutions 0.00N/AN/AN/ARGCRegencell Bioscience 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCXFCI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/AN/AME23andMe$208.78M0.06$0.54 per share0.93$2.34 per share0.21NEPTNeptune Wellness Solutions$52.62M0.00N/AN/A($91.90) per share0.00RGCRegencell BioscienceN/AN/AN/AN/A$0.02 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCXFCI Canadian Convertible Bond ETF CommonN/AN/A0.00∞N/AN/AN/AN/AN/AME23andMe-$666.70M-$15.45N/A∞N/A-183.39%-170.07%-62.13%N/ANEPTNeptune Wellness Solutions-$60.46M-$106.72N/AN/AN/A-128.13%N/A-141.94%N/ARGCRegencell Bioscience-$4.30MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCXFCI Canadian Convertible Bond ETF CommonC$0.484.52%N/AN/AN/AME23andMeN/AN/AN/AN/AN/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/AN/ARGCRegencell Bioscience$0.885.99%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCXFCI Canadian Convertible Bond ETF CommonN/AN/AN/AME23andMeN/A1.050.91NEPTNeptune Wellness SolutionsN/A0.230.10RGCRegencell BioscienceN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCXFCI Canadian Convertible Bond ETF CommonN/AME23andMe36.10%NEPTNeptune Wellness Solutions14.44%RGCRegencell Bioscience0.13%Insider OwnershipCompanyInsider OwnershipCXFCI Canadian Convertible Bond ETF CommonN/AME23andMe26.32%NEPTNeptune Wellness Solutions5.10%RGCRegencell Bioscience2.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCXFCI Canadian Convertible Bond ETF Common905.05 millionN/ANot OptionableME23andMe77026.83 million19.77 millionNot OptionableNEPTNeptune Wellness Solutions584.53 million4.30 millionNot OptionableRGCRegencell Bioscience10494.49 millionN/AN/ANEPT, CXF, ME, and RGC HeadlinesRecent News About These CompaniesRegencell Bioscience Holdings (RGC) Climbs 11% Over Last WeekSeptember 13 at 5:52 PM | finance.yahoo.comRegencell Bioscience: Down 80%, More Downside Is LikelySeptember 5, 2025 | seekingalpha.comRegencell Bioscience Holdings Ltd (RGC) - Investing.comAugust 24, 2025 | investing.comRGC Resources: The Impact Of MVPAugust 6, 2025 | seekingalpha.comRegencell (RGC) Completes 38-for-1 Stock SplitJuly 31, 2025 | msn.comRegencell Bioscience (RGC) Insanely Up Over 11,000% in H1July 18, 2025 | msn.comRGC - Regencell Bioscience Holdings Ltd Executives | MorningstarJuly 8, 2025 | morningstar.comMRegencell Bioscience (RGC) Nosedives 19.8% on Profit-TakingJuly 8, 2025 | msn.comRegencell Bioscience Stock Volatility Continues MondayJuly 8, 2025 | msn.comRGC - Regencell Bioscience Holdings Ltd Financials | MorningstarJuly 3, 2025 | morningstar.comMRegencell stock rally returns as company blames short selling for volatilityJuly 3, 2025 | msn.comRegencell Bioscience Appoints New Independent Director Amid Board ChangesJune 30, 2025 | tipranks.comRegencell Bioscience Reports Improved Financial Results for First Half of 2025June 30, 2025 | tipranks.comMystery $42 billion Chinese medical fortune collapses in daysJune 27, 2025 | msn.comRegencell's 82,000% Surge: The $33 Billion Stock Rally That Nobody Can ExplainJune 27, 2025 | finance.yahoo.comRegencell Bioscience Holdings Limited (RGC) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comRGC - Regencell Bioscience Holdings Ltd Price vs Fair Value | MorningstarJune 26, 2025 | morningstar.comMRegencell Bioscience Holdings Ltd (RGC)June 22, 2025 | investing.comRegencell Bioscience Holdings (NasdaqCM:RGC) Announces 38:1 Stock Split Effective June 2025June 20, 2025 | finance.yahoo.comThe company recently effected a 38-for-1 forward stock splitJune 20, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesNIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025Amazon Stock Sets Up for Breakout After Bullish CrossoverBy Sam Quirke | August 21, 2025Zillow Group Approaching Key Technical Levels: Is It Time to Buy?By Dan Schmidt | August 23, 2025Take Profits Now: 3 Overbought Stocks Primed for a PullbackBy Dan Schmidt | August 25, 2025NEPT, CXF, ME, and RGC Company DescriptionsCI Canadian Convertible Bond ETF Common TSE:CXFC$10.63 +0.16 (+1.53%) As of 09/12/2025 09:48 AM EasternThe investment objectives of First Asset Canadian Convertible Bond ETF are to provide holders with (i) quarterly cash distributions, and (ii) the opportunity for capital appreciation by investing on a capitalization weighted basis in a portfolio (the Convertible Portfolio) of Convertible Bonds of Canadian issuers. The Convertible ETF will invest on a capitalization weighted basis in Convertible Bonds which meet the Eligibility Criteria. Capitalization weightings are determined on the basis of a Convertible Bonds relative market capitalization to the total market capitalization of Convertible Bonds included in the Convertible Portfolio, on initial investment and on quarterly rebalancings.23andMe NASDAQ:ME23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to enhance patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing intellectual property associated with identified drug targets related to drug candidates under clinical development. The company's therapeutics product portfolio comprises 23ME-00610 (P006), a humanized monoclonal antibody, which is in phase 1/2a clinical trials to interfere with the ability of CD200R1 to interact with CD200 in cancer cells; and GSK6097608, an antibody that targets CD96 for attenuating T and NK cell anti-tumor immune responses. The company was incorporated in 2006 and is headquartered in South San Francisco, California.Neptune Wellness Solutions NASDAQ:NEPTNeptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada. Regencell Bioscience NASDAQ:RGC$14.70 +1.25 (+9.29%) As of 09/12/2025 04:00 PM EasternRegencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
